Search

Your search keyword '"Kotte, A.N."' showing total 9 results
Start Over Author "Kotte, A.N."
9 results on '"Kotte, A.N."'

1. EP-1624 First clinical experiences with SBRT on the 1.5 T MR-linac for pelvic lymph node oligometastases

Author

Werensteijn-Honingh, A.M., primary, Kroon, P.S., additional, Winkel, D., additional, Aalbers, E.M., additional, Van Asselen, B., additional, Bol, G.H., additional, Brown, K.J., additional, Eppinga, W.S.C., additional, Glitzner, M., additional, Breugel, E.N. De Groot-van, additional, Hackett, S.L., additional, Intven, M., additional, Kok, J.G.M., additional, Kotte, A.N., additional, Lagendijk, J.J.W., additional, Philippens, M.E.P., additional, Tijssen, R.H.N., additional, Wolthaus, J.W.H., additional, Woodings, S.J., additional, Raaymakers, B.W., additional, and Jürgenliemk-Schulz, I.M., additional

Published
2019
Full Text
View/download PDF

2. Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study

Author

Nowee, M.E., Voncken, F.E., Kotte, A.N., Goense, L., Rossum, P.S.N. van, Lier, A.L. van, Heijmink, S.W., Aleman, B.M.P., Nijkamp, J., Braam, P.M., Meijer, G.J, Lips, I.M., Nowee, M.E., Voncken, F.E., Kotte, A.N., Goense, L., Rossum, P.S.N. van, Lier, A.L. van, Heijmink, S.W., Aleman, B.M.P., Nijkamp, J., Braam, P.M., Meijer, G.J, and Lips, I.M.

Abstract

Contains fulltext : 207121.pdf (publisher's version ) (Open Access)

Published
2018

3. Pancreatic Adenocarcinoma Gross Tumor Volume Contouring on Computed Tomography as Compared With Magnetic Resonance Imaging: Results of an International Consensus Contouring Conference

Author

Hall, W.A., primary, Heerkens, H.D., additional, Paulson, E.S., additional, Meijer, G.J., additional, Kotte, A.N., additional, Knechtges, P., additional, Parikh, P.J., additional, Bassetti, M.F., additional, Lee, P., additional, Aitken, K.L., additional, Palta, M., additional, Myrehaug, S., additional, Koay, E.J., additional, Portelance, L., additional, Ben-Josef, E., additional, and Erickson, B.A., additional

Published
2017
Full Text
View/download PDF

4. Probabilistic treatment planning for pancreatic cancer treatment: prospective incorporation of respiratory motion shows only limited dosimetric benefit

Author

Lens, E., Kotte, A.N., Patel, A, Heerkens, H.D., Bal, M, Tienhoven, G. van, Bel, A., Horst, A. van der, Meijer, G.J, Lens, E., Kotte, A.N., Patel, A, Heerkens, H.D., Bal, M, Tienhoven, G. van, Bel, A., Horst, A. van der, and Meijer, G.J

Abstract

Contains fulltext : 173130.pdf (publisher's version ) (Open Access), BACKGROUND: We introduced a probabilistic treatment planning approach that prospectively incorporates respiratory-induced motion in the treatment plan optimization. The aim of this study was to determine the potential dosimetric benefit by comparing this approach to the use of an internal target volume (ITV). MATERIAL AND METHOD: We retrospectively compared the probabilistic respiratory motion-incorporated (RMI) approach to the ITV approach for 18 pancreatic cancer patients, for seven simulated respiratory amplitudes from 5 to 50 mm in the superior-inferior (SI) direction. For each plan, we assessed the target coverage (required: D98%>/=95% of 50 Gy prescribed dose). For the RMI plans, we investigated whether target coverage was robust against daily variations in respiratory amplitude. We determined the distance between the clinical target volume and the 30 Gy isodose line (i.e. dose gradient steepness) in the SI direction. To investigate the clinical benefit of the RMI approach, we created for each patient an ITV and RMI treatment plan for the three-dimensional (3D) respiratory amplitudes observed on their pretreatment 4D computed tomography (4DCT). We determined Dmean, V30Gy, V40Gy and V50Gy for the duodenum. RESULTS: All treatment plans yielded good target coverage. The RMI plans were robust against respiratory amplitude variations up to 10 mm, as D98% remained >/=95%. We observed steeper dose gradients compared to the ITV approach, with a mean decrease from 25.9 to 19.2 mm for a motion amplitude of 50 mm. For the 4DCT motion amplitudes, the RMI approach resulted in a mean decrease of 0.43 Gy, 1.1 cm3, 1.4 cm3 and 0.9 cm3 for the Dmean, V30Gy, V40Gy and V50Gy of the duodenum, respectively. CONCLUSION: The probabilistic treatment planning approach yielded significantly steeper dose gradients and therefore significantly lower dose to surrounding healthy tissues than the ITV approach. However, the observed dosimetric gain for clinically observed respiratory motion a

Published
2017

8. Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial.

Author

Lips, I.M., Heide, U.A. van der, Haustermans, K., Lin, E.N. van, Pos, F., Franken, S.P., Kotte, A.N., Gils, C.H. van, Vulpen, M. van, Lips, I.M., Heide, U.A. van der, Haustermans, K., Lin, E.N. van, Pos, F., Franken, S.P., Kotte, A.N., Gils, C.H. van, and Vulpen, M. van

Abstract

Contains fulltext : 98349.pdf (publisher's version ) (Open Access)

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results